Nadolol for Infantile Hemangiomas Previously Treated with Propranolol

Actas Dermosifiliogr. 2024 Feb;115(2):215-217. doi: 10.1016/j.ad.2023.05.025. Epub 2023 Jun 23.

[Article in English, Spanish]

Authors

M Colmenero Sendra¹, J Del Boz González², J M Segura Palacios³, I Valladares Millán³, M Eguiluz Solana⁴, M de Troya Martín³

Affiliations

¹ Servicio de Dermatología, Hospital Costa del Sol, Marbella, Málaga, España. Electronic address: sendracolmenero@gmail.com.
² Servicio de Dermatología, Hospital Carlos Haya, Málaga, España.
³ Servicio de Dermatología, Hospital Costa del Sol, Marbella, Málaga, España.
⁴ Unidad de Farmacia Hospitalaria, Hospital Costa del Sol, Marbella, Málaga, España.

PMID: 37356545
DOI: 10.1016/j.ad.2023.05.025

No abstract available

Publication types

Case Reports

MeSH terms

Administration, Oral
Adrenergic beta-Antagonists / therapeutic use
Hemangioma* / drug therapy
Hemangioma, Capillary* / drug therapy
Humans
Infant
Nadolol / therapeutic use
Propranolol / therapeutic use
Skin Neoplasms* / drug therapy
Treatment Outcome

Substances

Propranolol
Nadolol
Adrenergic beta-Antagonists